Management of punding in Parkinson’s disease: an open-label prospective study

被引:0
|
作者
A. Fasano
L. Ricciardi
M. Pettorruso
A. R. Bentivoglio
机构
[1] Università Cattolica del Sacro Cuore Largo Agostino Gemelli,Istituto di Neurologia
[2] 8,Department of Neurosciences, Psychiatry and Anaesthesiological Science
[3] Neuromed Institute,Department of Psychiatry
[4] University of Messina,undefined
[5] Catholic University of Sacred Heart,undefined
来源
Journal of Neurology | 2011年 / 258卷
关键词
Amantadine; Parkinson’s disease; Punding; Therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Punding, a peculiar stereotyped behavior characterized by intense fascination with complex, excessive, non-goal-oriented, repetitive activities, is a quite rare condition complicating Parkinson’s disease (PD). It is triggered by dopaminergic therapy and could have a strong impact on patient quality of life. No study has specifically investigated medical management of this condition, and only a few anecdotal reports have provided therapeutic hints. Given the suggested similarities to drug-induced dyskinesias, we have previously suggested a multistep algorithm for management of punding. We conducted a prospective open-label study on ten PD punders aimed at testing its validity. In two cases, reduction of levodopa therapy was efficacious; amantadine was effective in controlling punding in four cases; in the remaining cases, quetiapine was employed, with mild efficacy in two cases.
引用
收藏
页码:656 / 660
页数:4
相关论文
共 50 条
  • [31] Selegiline improves excessive daytime sleepiness in Parkinson’s disease: an open-label observational study
    Zhang Jinru
    Chen Juping
    Li Jia
    Li Jian
    Miao Hong
    Zhu Xiangyang
    Meng Meng
    Han Yang
    Chen Jing
    Cheng Xiaoyu
    Xiong Kangping
    Jin Hong
    Luo Weifeng
    Mao Chengjie
    Liu Chunfeng
    中华医学杂志英文版, 2022, 135 (14) : 1762 - 1764
  • [32] An open-label conversion study of pramipexole to ropinirole prolonged release in patients with Parkinson's disease
    Pahwa, R.
    Lyons, K. E.
    MOVEMENT DISORDERS, 2008, 23 (01) : S314 - S314
  • [33] An open-label extension study to determine the safety of pimavanserin in patients with Parkinson's disease and psychosis
    Mills, R.
    Johnson, A. D.
    Bahr, D.
    Williams, H.
    Revell, S.
    MOVEMENT DISORDERS, 2009, 24 : S268 - S269
  • [34] Update on the ADOPTION Study: Randomised, Open-Label Exploratory Trial of Opicapone in Parkinson's Disease
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Stocchi, F.
    Antonini, A.
    Moreira, J.
    Guimaraes, B.
    Rocha, J. F.
    MOVEMENT DISORDERS, 2023, 38 : S22 - S23
  • [35] Update on the ADOPTION Study: Randomised, Open-Label Exploratory Trial of Opicapone in Parkinson's Disease
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Stocchi, F.
    Antonini, A.
    Costa, R.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2023, 38 : S22 - S22
  • [36] An Open-Label Extension Study To Determine the Safety of Pimavanserin in Patients with Parkinson's Disease and Psychosis
    Mills, Roger
    Johnson, Ann D.
    Williams, Hilde
    Bahr, Daun
    Revell, Stephen
    NEUROLOGY, 2009, 72 (11) : A319 - A319
  • [37] Expiratory muscle training for the impaired loudness of speech in Parkinson's disease: An open-label study
    Tomita, S.
    Oeda, T.
    Umemura, A.
    Kohsaka, M.
    Park, K.
    Yamamoto, K.
    Sugiyama, H.
    Sawada, H.
    MOVEMENT DISORDERS, 2016, 31 : S664 - S664
  • [38] Selegiline improves excessive daytime sleepiness in Parkinson's disease: an open-label observational study
    Zhang, Jinru
    Chen, Juping
    Li, Jia
    Li, Jian
    Miao, Hong
    Zhu, Xiangyang
    Meng, Meng
    Han, Yang
    Chen, Jing
    Cheng, Xiaoyu
    Xiong, Kangping
    Jin, Hong
    Luo, Weifeng
    Mao, Chengjie
    Liu, Chunfeng
    CHINESE MEDICAL JOURNAL, 2022, 135 (14) : 1762 - 1764
  • [39] Escitalopram for major depression in Parkinson's disease: An open-label, flexible-dosage study
    Weintraub, Daniel
    Taraborelli, Donna
    Morales, Knashawn H.
    Duda, John E.
    Katz, Ira R.
    Stern, Matthew B.
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2006, 18 (03) : 377 - 383
  • [40] An open-label extension study of modafinil for the treatment of daytime sleepiness in patients with Parkinson's disease
    Adler, CH
    Caviness, JN
    Hentz, JG
    Lind, M
    Tiede, J
    SLEEP, 2002, 25 : A251 - A252